Role of immunotherapy in localized muscle invasive urothelial cancer

The standard treatment for non-metastatic muscle-invasive bladder cancer (MIBC) is cisplatin-based neoadjuvant chemotherapy followed by radical cystectomy or trimodality therapy with chemoradiation in select patients. Pathologic complete response (pCR) to neoadjuvant chemotherapy is a reliable predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Jasmeet, Choi, Woonyoung, Geynisman, Daniel M., Plimack, Elizabeth R., Ghatalia, Pooja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461126/
https://www.ncbi.nlm.nih.gov/pubmed/34567274
http://dx.doi.org/10.1177/17588359211045858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461126/
https://www.ncbi.nlm.nih.gov/pubmed/34567274
http://dx.doi.org/10.1177/17588359211045858

Ejemplares similares